Odaily Planet Daily News: Nasdaq-listed Prenetics announced that it has reached a final agreement to transfer its ownership in ACT Genomics Holdings Company Limited to Delta Electronics Co., Ltd. for approximately US$71.78 million. The divestiture of ACT Genomics significantly strengthens Prenetics' financial foundation, with estimated cash reserves of approximately US$86 million and estimated cash and short-term assets of US$117 million. The company maintains a debt-free balance sheet with zero debt, allowing it to explore other financial management options, including digital asset adoption and Bitcoin financial strategies. (Globenewswire)